Therapeutic Interventions for Adjustment Disorder: A Systematic Review.
Journal
American journal of therapeutics
ISSN: 1536-3686
Titre abrégé: Am J Ther
Pays: United States
ID NLM: 9441347
Informations de publication
Date de publication:
Historique:
pubmed:
11
6
2020
medline:
22
4
2021
entrez:
11
6
2020
Statut:
ppublish
Résumé
Adjustment disorder requires therapeutic intervention because of its complications, which include a significant risk of suicide, but evidence-based therapeutic guidelines are not available. The main problem is related to answer to the following question: What is the optimal therapeutic approach to adjustment disorder? In this respect we review all randomized controlled trials that aimed to investigate therapeutic interventions for adjustment disorder in adult populations. Comprehensive search of the electronic database PubMed (January 1980-June 2019). The review included clinical trials that aimed to investigate a psychological or pharmacological treatment for adjustment disorder in adult population and reported outcome data for therapeutic interventions. The search identified 23 studies that fulfilled the inclusion criteria for this review. Pharmacotherapy interventions were the focus of 11 studies that used various medications and dosages including viloxazine, lormetazepam, S-adenosylmethionine, pivagabine, trazodone, clorazepate, etifoxine, lorazepam, diazepam, afobazole, and plant extracts (Kava-kava, Euphytose, and Ginkgo biloba) on a total number of 1020 patients. Psychotherapy interventions were identified in 12 studies that used mirror therapy, short-term dynamic psychotherapy, yoga meditation, body-mind-spirit technique, mindfulness, bibliotherapy (self-help manual), humor training, and cognitive behavioral therapy. Psychotherapy seems indicated for mildly symptomatic adjustment disorder. Given the fact that adjustment disorder with severe symptoms is associated with a high risk of suicidal ideation and suicide attempts, clinicians must consider the potential benefit of using psychotropic agents such as benzodiazepines, antidepressants, or etifoxine.
Sections du résumé
BACKGROUND
BACKGROUND
Adjustment disorder requires therapeutic intervention because of its complications, which include a significant risk of suicide, but evidence-based therapeutic guidelines are not available.
AREAS OF UNCERTAINTY
UNASSIGNED
The main problem is related to answer to the following question: What is the optimal therapeutic approach to adjustment disorder? In this respect we review all randomized controlled trials that aimed to investigate therapeutic interventions for adjustment disorder in adult populations.
DATA SOURCES
METHODS
Comprehensive search of the electronic database PubMed (January 1980-June 2019). The review included clinical trials that aimed to investigate a psychological or pharmacological treatment for adjustment disorder in adult population and reported outcome data for therapeutic interventions.
RESULTS
RESULTS
The search identified 23 studies that fulfilled the inclusion criteria for this review. Pharmacotherapy interventions were the focus of 11 studies that used various medications and dosages including viloxazine, lormetazepam, S-adenosylmethionine, pivagabine, trazodone, clorazepate, etifoxine, lorazepam, diazepam, afobazole, and plant extracts (Kava-kava, Euphytose, and Ginkgo biloba) on a total number of 1020 patients. Psychotherapy interventions were identified in 12 studies that used mirror therapy, short-term dynamic psychotherapy, yoga meditation, body-mind-spirit technique, mindfulness, bibliotherapy (self-help manual), humor training, and cognitive behavioral therapy.
CONCLUSIONS
CONCLUSIONS
Psychotherapy seems indicated for mildly symptomatic adjustment disorder. Given the fact that adjustment disorder with severe symptoms is associated with a high risk of suicidal ideation and suicide attempts, clinicians must consider the potential benefit of using psychotropic agents such as benzodiazepines, antidepressants, or etifoxine.
Identifiants
pubmed: 32520732
doi: 10.1097/MJT.0000000000001170
pii: 00045391-202008000-00007
doi:
Substances chimiques
Antidepressive Agents, Second-Generation
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e375-e386Références
American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. 1st ed. Washington, DC: American Psychiatric Association; 1952.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
World Health Organization. Mental Disorders: Glossary and Guide to Their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. Albany, NY: World Health Organization; 1978.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Description and Diagnostic Guidelines (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association Publishing; 2013.
World Health Organization. International Classification of Diseases, 2017, Version 11 (ICD-11) [Beta Draft]. Available at: https://icd.who.int/dev11/l-m/en.
Huyse FJ, Herzog T, Lobo A, et al. Consultation-liaison psychiatric service delivery: Results from a European study. Gen Hosp Psychiatry. 2001;23:124–132.
Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–174.
Strain JJ, Smith GC, Hammer JS, et al. Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry. 1998;20:139–149.
Kryzhanovskaya L, Canterbury R. Suicidal behavior in patients with adjustment disorders. Crisis. 2001;22:125–131.
Fernandez A, Mendive JM, Salvador-Carulla L, et al. Adjustment disorders in primary care: prevalence, recognition and use of services. Br J Psychiatry. 2012;201:137–142.
O'Donnell ML, Alkemade NR, Creamer MC, et al. A longitudinal study of adjustment disorder after trauma exposure. Am J Psychiatry. 2016;173:1231–1238.
Gradus JL. Prevalence and prognosis of stress disorders: a review of the epidemiologic literature. Clin Epidemiol. 2017;9:251.
Glaesmer H, Romppel M, Brähler E, et al. Adjustment disorder as proposed for ICD-11: dimensionality and symptom differentiation. Psychiatry Res. 2015;229:940–948.
Killikelly C, Lorenz L, Bauer S, et al. Prolonged grief disorder: its co-occurrence with adjustment disorder and post-traumatic stress disorder in a bereaved Israeli general-population sample. J Affect Disord. 2019;249:307–314.
Perkonigg A, Lorenz L, Maercker A. Prevalence and correlates of ICD-11 adjustment disorder: findings from the Zurich adjustment disorder study. Int J Clin Health Psychol. 2018;18:209–217.
Casey P. Adjustment disorder: new developments. Curr Psychiatry Rep. 2014;16:451.
Appart A, Lange AK, Sievert I, et al. Adjustment disorder and DSM-5: a review [in French]. Encephale 2017;43:41–46.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341.
Van der Klink JJL, Blonk RWB, Schene AH, et al. Reducing long term sickness absence by an activating intervention in adjustment disorders: a cluster randomised controlled design. Occup Environ Med. 2003;60:429–437.
Ruesch M, Helmes AW, Bengel J. Cognitive behavioral group therapy for patients with physical diseases and comorbid depressive or adjustment disorders on a waiting list for individual therapy: results from a randomized controlled trial. BMC Psychiatry. 2017;17:34.
Sanz Cruces JM, García Cuenca IM, Lacomba-Trejo L, et al. Group therapy for patients with adjustment disorder in primary care. Spanish J Psychol. 2018;21:e501–e508.
Bachem R, Maercker A. Self-help interventions for adjustment disorder problems: a randomized waiting-list controlled study in a sample of burglary victims. Cogn Behav Ther. 2016;45:397–413.
Barak A, Hen L, Boniel-Nissim M, et al. Comprehensive review and a meta-analysis of the effectiveness of internet-based psychotherapeutic interventions. J Technol Hum Serv. 2008;26:109–160.
Cuijpers P, Marks IM, van Straten A, et al. Computer-aided psychotherapy for anxiety disorders: a meta-analytic review. Cogn Behav Ther. 2009;38:66–82.
Olthuis JV, Watt MC, Stewart SH. Therapist-delivered distance cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2011;3:4.
Andersson G, Carlbring P, Berger T, et al. What makes internet therapy work? Cogn Behav Ther. 2009;38:55–60.
Kleiboer A, Donker T, Seekles W, et al. Randomized controlled trial on the role of support in internet-based problem solving therapy for depression and anxiety. Behav Res Ther. 2015;72:63–71.
Berger T, Hämmerli K, Gubser N, et al. Internet-based treatment of depression: a randomized controlled trial comparing guided with unguided self-help. Cogn Behav Ther. 2011;40:37–41.
Karyotaki E, Riper H, Twisk J, et al. Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms. JAMA Psychiat. 2017;74:351.
Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017;34:555–565.
Jonas E, Rimsaite Z, Goda G, et al. Internet-based self-help intervention for ICD-11 adjustment disorder: preliminary findings. Psychiatr Q. 2018;89:451–460.
Grepmair L, Mitterlehner F, Loew T, et al. Promoting mindfulness in psychotherapists in training influences the treatment results of their patients: a randomized, double-blind, controlled study. Psychother Psychosom 2007;76:332e8.
Masud Y, Afshin A, Javad HV, et al. Effects of Transcendental Meditation on mental health: a before-after study. Clin Pract Epidemiol Ment Health 2008;4:25.
Srivastava M, Talukdar U, Lahan V. Meditation for the management of adjustment disorder anxiety and depression. Complement Ther Clin Pract. 2011;17:241–245.
Malan D. Toward the Validation of Dynamic Psychotherapy. New York, NY: Plenum Publishing Corp; 1976.
Sifneos P. Short-term Dynamic Psychotherapy Evaluation and Technique. New York, NY: Plenum; 1987.
Crits-Christoph P. The efficacy of brief dynamic psychotherapy: a meta-analysis. Am J Psychiatry 1992;149:151–158.
Leichsenring F, Leibing E. The effectiveness of psychodynamic psychotherapy and cognitive-behavioral therapy in personality disorders: a meta-analysis. Am J Psychiatry 2003;160:1223–1232.
Kramer U, Despland JN, Michel L. Change in defense mechanisms and coping over the Course of short-term dynamic psychotherapy for adjustment disorder. J Clin Psychol. 2010;66:1232–1241.
Kramer U, Pascual-Leone A, Despland JN, et al. One minute of grief: emotional processing in short-term dynamic psychotherapy for adjustment disorder. J Consult Clin Psychol. 2015;83:187–198.
Gonza ́lez-Jaimes EI, Turnbull-Plaza B. Selection of psychotherapeutic treatment for adjustment disorder with depressive mood due to acute myocardial infarction. Arch Med Res. 2003;34:298–304.
Hsiao FH, Lai YM, Chen YT, et al. Efficacy of psychotherapy on diurnal cortisol patterns and suicidal ideation in adjustment disorder with depressed mood. Gen Hosp Psychiatry 2014;36:214–219.
Tagalidou N, Distlberger E, Loderer V, et al. Efficacy and feasibility of a humor training for people suffering from depression, anxiety, and adjustment disorder: a randomized controlled trial. BMC Psychiatry. 2019;19:93.
De Leo D. Treatment of adjustment disorders: a comparative evaluation. Psychol Rep. 1989;64:51–54.
Terranova R, Gilotta SM, Luca S. Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders. Arzneimittelforschung. 1997;47:1325–1328.
Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1–5.
Bourin M, Bougerol T, Guitton B, et al. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol. 1997;11:127–132.
Servant D, Graziani PL, Moyse D, et al. Treatment of adjustment disorder with anxiety: efficacy and tolerance of etifoxine in a double-blind controlled study. L'Encephale. 1998;24:569–574.
Nguyen N, Fakra E, Pradel V, et al. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Hum Psychopharmacol. 2006;21:139–149.
Guy W. Clinical Global Impression Scale (CGI). ECDEU Assessment Manual for Psychopharmacology. Washington, DC: National Institute of Mental Health-US Dept of Health, Education, and Welfare publication (ADM); 1976:76–338.
Stein DJ. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial. Adv Ther. 2015;32:57–68.
Razavi D, Kormoss N, Collard A, et al. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Res. 1999;27:264–272.
De Wit S, Cremers L, Hirsch D, et al. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study. J Int Med Res. 1999;27:223–232.
Woelk H, Arnoldt KH, Kieser M, et al. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res. 2007;41:472–480.
Syunyakov TS, Neznamov GG. Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: results of a multicenter randomized comparative study of diazepam [in Russian]. Ter Arkh. 2016;88:73–86.
Maercker A, Bachem RC, Lorenz L, et al. Adjustment disorders are uniquely suited for ehealth interventions: concept and case study. JMIR Ment Health. 2015;2:e15.
Einsle F, Kollner V, Dannemann S, et al. Development and validation of a self-report for the assessment of adjustment disorders. Psychol Health Med. 2010;15:584–595.
Lorenz L, Bachem RC, Maercker A. The adjustment disorder–new module 20 as a screening instrument: cluster analysis and cut-off values. Int J Occup Environ Med. 2016;7:215–220.
Michael B, Williams JBW, Karg RS, et al. Structured Clinical Interview for DSM-5 (SCID-5)—Research Version: American Psychiatry Publishing; 2016.
Stahl SM. Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. J Clin Psychiatry. 2002;63:756–757.
Galecki P, Zboralski K, Florkowski A. The efficacy and safety of trazodone in the treatment of adjustment disorders–naturalistic research [in Polish]. Pol Merkur Lekarski. 2005;19:183–187.